Skip to search formSkip to main contentSkip to account menu

Human poliovirus 2

Known as: Lansing Virus, Poliovirus Type 2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
BACKGROUND In July 2016, Sri Lanka replaced 1 intramuscular dose of inactivated poliovirus vaccine (IPV) with 2 doses of… 
2017
2017
The Global Polio Eradication Initiative (GPEI) continues to make progress toward the eradication target. Only one of the three… 
1991
1991
A chimeric type 1/type 2 poliovirus (v510), in which the antigenic site 1 (Ag1) of poliovirus type 1 (PV-1) Mahoney was replaced… 
1989
1989
Enteroviruses can cause persistent central nervous system (CNS) infections in agammaglobulinemic individuals. Because these… 
1980
1980
Virion RNA (vRNA) from poliovirus type 1 (PV1), poliovirus type 2 (PV2), and coxsackie virus B1 (Cox B1) were treated with… 
Highly Cited
1975
Highly Cited
1975
The effect of concanavalin A (Con A) on the course of early infection of HeLa cells with purified radioactive human rhinovirus…